← Open Payments lookup

MEMOUNA FOUDJOU: Open Payments

NPI 1578967972 · ROCKVILLE, MD. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.

See the full provider profile for registry, prescribing and billing details.

Industry payments (Sunshine Act)

Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.

$2,500 in 125 payments from 14 companies in 2025. Trend: 2023 $2,098 · 2024 $3,053 · 2025 $2,500

Food & beverage: $2,500
CompanyPaymentsAmount
Neurocrine BioSciences, Inc.22$418
ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.)13$404
Teva Pharmaceuticals USA, Inc.16$383
Alkermes, Inc.29$366
ABBVIE INC.15$229
Otsuka America Pharmaceutical, Inc.8$162
Janssen Pharmaceuticals, Inc6$155
Supernus Pharmaceuticals, Inc.2$76
Lundbeck LLC3$71
Vanda Pharmaceuticals Inc.2$68

Products named: INGREZZA, CAPLYTA, ARISTADA, UZEDY, VRAYLAR, AUSTEDO XR, REXULTI, INVEGA SUSTENNA.

Industry payments across MD — which companies pay providers there.